Free Trial

ECARX (ECXWW) Financials

$0.04 +0.00 (+4.57%)
As of 04/17/2025 11:57 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for ECARX

Annual Income Statements for ECARX

This table shows ECARX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-83 -223 -278 -132 -128
Consolidated Net Income / (Loss)
-68 -184 -233 -143 -136
Net Income / (Loss) Continuing Operations
-68 -185 -233 -143 -136
Total Pre-Tax Income
-68 -184 -229 -144 -135
Total Operating Income
-66 -157 -236 -129 -121
Total Gross Profit
85 128 144 179 158
Total Revenue
345 436 516 662 762
Operating Revenue
345 436 516 662 762
Total Cost of Revenue
260 308 372 483 604
Operating Cost of Revenue
260 308 372 483 604
Total Operating Expenses
151 285 380 309 279
Selling, General & Admin Expense
33 95 190 131 106
Research & Development Expense
109 190 193 178 173
Other Operating Expenses / (Income)
0.03 - -3.03 -0.75 -0.06
Total Other Income / (Expense), net
-1.43 -27 7.27 -14 -15
Interest Expense
9.09 21 6.46 11 18
Interest & Investment Income
4.40 1.53 -8.42 -1.77 8.56
Other Income / (Expense), net
3.26 -7.52 22 -1.34 -4.78
Income Tax Expense
0.04 1.08 4.21 -0.51 0.20
Preferred Stock Dividends Declared
16 38 51 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.05 -0.44 -6.23 -11 -7.89
Basic Earnings per Share
($2.27) ($5.99) ($1.16) ($0.39) ($0.38)
Weighted Average Basic Shares Outstanding
238.59M 236.69M 239.30M 337.41M 336.64M
Diluted Earnings per Share
($2.27) ($5.99) ($1.16) ($0.39) ($0.38)
Weighted Average Diluted Shares Outstanding
238.59M 236.69M 239.30M 337.41M 336.64M
Weighted Average Basic & Diluted Shares Outstanding
- - 337.40M 337.95M 340.13M

Quarterly Income Statements for ECARX

No quarterly income statements for ECARX are available.


Annual Cash Flow Statements for ECARX

This table details how cash moves in and out of ECARX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
-215 -2.31 -13 -43 -32
Net Cash From Operating Activities
-57 -142 -67 -174 -59
Net Cash From Continuing Operating Activities
-57 -142 -67 -174 -59
Net Income / (Loss) Continuing Operations
-68 -185 -233 -143 -136
Consolidated Net Income / (Loss)
-68 -185 -233 -143 -136
Depreciation Expense
9.07 10 11 12 20
Amortization Expense
8.51 16 0.00 0.40 0.29
Non-Cash Adjustments To Reconcile Net Income
-15 59 52 -24 27
Changes in Operating Assets and Liabilities, net
8.09 -43 104 -19 29
Net Cash From Investing Activities
-14 -188 -45 83 -8.21
Net Cash From Continuing Investing Activities
-14 -188 -45 83 -8.21
Purchase of Property, Plant & Equipment
-11 -13 -23 -8.76 -16
Acquisitions
0.00 -181 -15 0.00 -15
Purchase of Investments
0.00 -7.64 -8.30 -53 -42
Sale of Property, Plant & Equipment
0.00 0.00 0.25 0.30 0.22
Sale and/or Maturity of Investments
0.00 14 4.26 34 42
Other Investing Activities, net
-3.38 0.00 -3.99 112 22
Net Cash From Financing Activities
175 333 95 42 36
Net Cash From Continuing Financing Activities
-142 333 95 42 36
Repayment of Debt
-26 -201 -298 -208 -260
Repurchase of Preferred Equity
-159 72 0.00 0.00 -3.00
Payment of Dividends
0.00 0.00 -20 -11 0.00
Issuance of Debt
12 156 362 254 301
Issuance of Preferred Equity
32 506 23 0.00 0.00
Issuance of Common Equity
0.00 0.00 6.34 0.00 0.00
Other Financing Activities, net
0.00 -198 22 6.87 -2.65
Effect of Exchange Rate Changes
-1.54 -5.02 4.19 5.85 -0.40
Cash Interest Paid
0.45 4.55 4.19 8.99 15
Cash Income Taxes Paid
0.01 1.97 0.00 0.28 1.75

Quarterly Cash Flow Statements for ECARX

No quarterly cash flow statements for ECARX are available.


Annual Balance Sheets for ECARX

This table presents ECARX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Total Assets
622 686 607 517
Total Current Assets
386 559 469 388
Cash & Equivalents
138 125 81 44
Restricted Cash
3.61 5.94 3.82 5.95
Short-Term Investments
- 0.00 19 18
Note & Lease Receivable
22 26 7.70 2.30
Accounts Receivable
156 314 272 223
Inventories, net
35 26 23 32
Prepaid Expenses
31 62 62 62
Plant, Property, & Equipment, net
16 20 17 22
Total Noncurrent Assets
221 107 121 107
Long-Term Investments
212 51 42 2.17
Goodwill
- - 0.00 3.52
Intangible Assets
4.87 6.50 25 42
Other Noncurrent Operating Assets
3.43 49 53 59
Total Liabilities & Shareholders' Equity
622 686 607 517
Total Liabilities
551 691 724 756
Total Current Liabilities
474 569 599 702
Short-Term Debt
166 151 170 270
Accounts Payable
119 245 300 292
Accrued Expenses
72 114 87 86
Current Deferred & Payable Income Tax Liabilities
0.00 3.13 2.22 2.79
Other Current Liabilities
117 57 39 51
Total Noncurrent Liabilities
77 122 125 54
Long-Term Debt
0.00 64 64 0.00
Noncurrent Deferred & Payable Income Tax Liabilities
- - 0.00 2.08
Other Noncurrent Operating Liabilities
77 58 61 51
Commitments & Contingencies
0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-645 -5.00 -117 -239
Total Preferred & Common Equity
-644 -28 -129 -241
Total Common Equity
-669 -28 -129 -241
Common Stock
-25 858 859 851
Retained Earnings
-645 -831 -940 -1,042
Treasury Stock
- - 0.00 -1.02
Accumulated Other Comprehensive Income / (Loss)
0.95 -56 -49 -50
Noncontrolling Interest
-0.90 23 12 2.02

Quarterly Balance Sheets for ECARX

No quarterly balance sheets for ECARX are available.


Annual Metrics and Ratios for ECARX

This table displays calculated financial ratios and metrics derived from ECARX's official financial filings.

Metric 2020 2021 2022 2023 2024
Growth Metrics
- - - - -
Revenue Growth
0.00% 26.52% 18.42% 28.17% 15.10%
EBITDA Growth
0.00% -205.42% -46.58% 41.85% 11.06%
EBIT Growth
0.00% -161.27% -30.07% 38.95% 3.79%
NOPAT Growth
0.00% -137.05% -50.41% 45.24% 6.49%
Net Income Growth
0.00% -172.21% -26.49% 38.62% 5.19%
EPS Growth
0.00% -163.88% 80.59% 66.20% 3.44%
Operating Cash Flow Growth
0.00% -151.51% 53.02% -159.63% 66.06%
Free Cash Flow Firm Growth
0.00% 0.00% -4,912.84% 88.84% -115.08%
Invested Capital Growth
0.00% 0.00% 123.51% -204.97% -36.60%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - -
Gross Margin
24.60% 29.40% 27.90% 27.08% 20.75%
EBITDA Margin
-13.16% -31.77% -39.33% -17.84% -13.79%
Operating Margin
-19.21% -35.99% -45.71% -19.53% -15.86%
EBIT Margin
-18.26% -37.71% -41.42% -19.73% -16.49%
Profit (Net Income) Margin
-19.63% -42.24% -45.12% -21.61% -17.80%
Tax Burden Percent
100.05% 100.35% 101.84% 99.64% 100.15%
Interest Burden Percent
107.45% 111.62% 106.96% 109.91% 107.77%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% -191.17% -510.06% 234.23% 76.15%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% -1,129.93% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% -26.42% -32.70% -20.21% -22.37%
Return on Assets (ROA)
0.00% -29.60% -35.62% -22.13% -24.15%
Return on Common Equity (ROCE)
0.00% 1,326.95% 3,892.94% 302.75% 79.20%
Return on Equity Simple (ROE_SIMPLE)
0.00% 28.61% 818.32% 110.55% 56.25%
Net Operating Profit after Tax (NOPAT)
-46 -110 -165 -90 -85
NOPAT Margin
-13.45% -25.19% -32.00% -13.67% -11.10%
Net Nonoperating Expense Percent (NNEP)
0.00% -69.93% -75.16% 87.02% 35.38%
Return On Investment Capital (ROIC_SIMPLE)
- - -78.94% -77.03% -271.18%
Cost of Revenue to Revenue
75.40% 70.60% 72.10% 72.92% 79.25%
SG&A Expenses to Revenue
9.59% 21.87% 36.78% 19.82% 13.97%
R&D to Revenue
31.50% 43.52% 37.42% 26.90% 22.65%
Operating Expenses to Revenue
43.81% 65.40% 73.61% 46.61% 36.62%
Earnings before Interest and Taxes (EBIT)
-63 -164 -214 -131 -126
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-45 -139 -203 -118 -105
Valuation Ratios
- - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.00 1.61 0.94
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 1.76 1.20
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - -
Debt to Equity
0.00 1.73 -42.90 -2.00 -1.13
Long-Term Debt to Equity
0.00 0.00 -12.77 -0.55 0.00
Financial Leverage
0.00 -2.21 -1.97 -0.99 -0.81
Leverage Ratio
0.00 6.46 14.32 -10.58 -3.15
Compound Leverage Factor
0.00 7.21 15.32 -11.63 -3.40
Debt to Total Capital
0.00% 63.30% 102.39% 199.71% 866.21%
Short-Term Debt to Total Capital
0.00% 63.30% 71.92% 145.07% 866.21%
Long-Term Debt to Total Capital
0.00% 0.00% 30.47% 54.64% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 281.89% 11.22% 10.43% 6.48%
Common Equity to Total Capital
0.00% -254.72% -13.60% -110.14% -772.69%
Debt to EBITDA
0.00 -1.20 -1.06 -1.99 -2.57
Net Debt to EBITDA
0.00 1.35 -0.16 -0.75 -1.90
Long-Term Debt to EBITDA
0.00 0.00 -0.31 -0.54 0.00
Debt to NOPAT
0.00 -1.51 -1.30 -2.59 -3.19
Net Debt to NOPAT
0.00 1.71 -0.20 -0.98 -2.36
Long-Term Debt to NOPAT
0.00 0.00 -0.39 -0.71 0.00
Altman Z-Score
0.00 0.00 0.00 -1.16 -2.31
Noncontrolling Interest Sharing Ratio
0.00% 794.11% 863.23% -29.25% -4.01%
Liquidity Ratios
- - - - -
Current Ratio
0.00 0.81 0.98 0.78 0.55
Quick Ratio
0.00 0.67 0.82 0.63 0.41
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
0.00 6.42 -309 -34 -74
Operating Cash Flow to CapEx
-532.52% -1,058.23% -296.58% -2,053.69% -380.55%
Free Cash Flow to Firm to Interest Expense
0.00 0.31 -47.83 -3.08 -4.04
Operating Cash Flow to Interest Expense
-6.22 -6.90 -10.36 -15.55 -3.22
Operating Cash Flow Less CapEx to Interest Expense
-7.39 -7.55 -13.85 -16.30 -4.06
Efficiency Ratios
- - - - -
Asset Turnover
0.00 0.70 0.79 1.02 1.36
Accounts Receivable Turnover
0.00 2.79 2.20 2.26 3.07
Inventory Turnover
0.00 8.79 12.11 19.65 22.08
Fixed Asset Turnover
0.00 26.94 28.35 35.54 39.10
Accounts Payable Turnover
0.00 2.58 2.05 1.77 2.04
Days Sales Outstanding (DSO)
0.00 130.63 166.09 161.60 118.70
Days Inventory Outstanding (DIO)
0.00 41.55 30.15 18.57 16.53
Days Payable Outstanding (DPO)
0.00 141.67 178.45 206.10 179.04
Cash Conversion Cycle (CCC)
0.00 30.51 17.79 -25.92 -43.80
Capital & Investment Metrics
- - - - -
Invested Capital
0.00 -116 27 -29 -39
Invested Capital Turnover
0.00 -7.50 -11.61 -974.81 -22.45
Increase / (Decrease) in Invested Capital
0.00 -116 144 -56 -11
Enterprise Value (EV)
0.00 0.00 0.00 1,167 915
Market Capitalization
0.00 0.00 0.00 1,066 713
Book Value per Share
$0.00 ($2.83) ($0.12) ($0.38) ($0.71)
Tangible Book Value per Share
$0.00 ($2.85) ($0.15) ($0.46) ($0.85)
Total Capital
0.00 263 209 117 31
Total Debt
0.00 166 214 235 270
Total Long-Term Debt
0.00 0.00 64 64 0.00
Net Debt
0.00 -188 32 88 200
Capital Expenditures (CapEx)
11 13 23 8.46 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -64 9.12 -63 -112
Debt-free Net Working Capital (DFNWC)
0.00 77 140 40 -44
Net Working Capital (NWC)
0.00 -89 -11 -130 -314
Net Nonoperating Expense (NNE)
21 74 68 53 51
Net Nonoperating Obligations (NNO)
0.00 -213 32 88 200
Total Depreciation and Amortization (D&A)
18 26 11 12 21
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -14.67% 1.77% -9.59% -14.73%
Debt-free Net Working Capital to Revenue
0.00% 17.75% 27.07% 6.09% -5.78%
Net Working Capital to Revenue
0.00% -20.37% -2.08% -19.66% -41.25%
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($7.92) ($2.79) ($0.38)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 239.30M 337.41M 336.64M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($1.15) ($2.79) ($0.38)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 239.30M 337.41M 336.64M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 337.40M 337.95M 340.13M
Normalized Net Operating Profit after Tax (NOPAT)
-46 -110 -165 -90 -85
Normalized NOPAT Margin
-13.45% -25.19% -32.00% -13.67% -11.10%
Pre Tax Income Margin
-19.62% -42.10% -44.30% -21.69% -17.77%
Debt Service Ratios
- - - - -
EBIT to Interest Expense
-6.92 -7.97 -33.12 -11.69 -6.86
NOPAT to Interest Expense
-5.10 -5.32 -25.59 -8.10 -4.62
EBIT Less CapEx to Interest Expense
-8.09 -8.62 -36.62 -12.45 -7.70
NOPAT Less CapEx to Interest Expense
-6.27 -5.97 -29.08 -8.86 -5.46
Payout Ratios
- - - - -
Dividend Payout Ratio
0.00% 0.00% -8.52% -7.74% 0.00%
Augmented Payout Ratio
-1.93% -0.85% -8.52% -7.74% 0.00%

Quarterly Metrics and Ratios for ECARX

No quarterly metrics and ratios for ECARX are available.


Frequently Asked Questions About ECARX's Financials

When does ECARX's financial year end?

According to the most recent income statement we have on file, ECARX's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has ECARX's net income changed over the last 4 years?

ECARX's net income appears to be on an upward trend, with a most recent value of -$135.61 million in 2024, rising from -$67.67 million in 2020. The previous period was -$143.03 million in 2023.

What is ECARX's operating income?
ECARX's total operating income in 2024 was -$120.87 million, based on the following breakdown:
  • Total Gross Profit: $158.12 million
  • Total Operating Expenses: $278.99 million
How has ECARX revenue changed over the last 4 years?

Over the last 4 years, ECARX's total revenue changed from $344.69 million in 2020 to $761.89 million in 2024, a change of 121.0%.

How much debt does ECARX have?

ECARX's total liabilities were at $755.69 million at the end of 2024, a 4.4% increase from 2023, and a 37.1% increase since 2021.

How much cash does ECARX have?

In the past 3 years, ECARX's cash and equivalents has ranged from $44.39 million in 2024 to $137.77 million in 2021, and is currently $44.39 million as of their latest financial filing in 2024.

How has ECARX's book value per share changed over the last 4 years?

Over the last 4 years, ECARX's book value per share changed from 0.00 in 2020 to -0.71 in 2024, a change of -71.3%.



This page (NASDAQ:ECXWW) was last updated on 4/21/2025 by MarketBeat.com Staff
From Our Partners